A major finding in the present study is that by gradually releasing TFV and TAF at concentrations sufficient to provide protection of CD4+ T cells from HIV infection, epithelial cells and fibroblasts extend ARV-mediated protection by providing a reservoir that lengthens the effectiveness of TFV and TAF beyond their initial application. This evidence concerns the gene CD4 and HIV infectious disease.